Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Imaging-guided selection of patients with ischemic heart failure for high-risk revascularization improves identification of those with the highest clinical benefit

Circulation: Cardiovascular Imaging

Volumn 5, Issue 2, 2012, Pages 262-270

  Mielniczuk, Lisa M ^a   Beanlands, Rob S ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; DETERIORATION; DYSPNEA; ECHOCARDIOGRAPHY; EMERGENCY WARD; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; ISCHEMIC HEART DISEASE; LUNG EDEMA; MALE; MEDICAL HISTORY; MITRAL VALVE REGURGITATION; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TERTIARY HEALTH CARE; CONVALESCENCE; DIAGNOSTIC IMAGING; HEART MUSCLE; HEART MUSCLE ISCHEMIA; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK ASSESSMENT; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE SURVIVAL; TREATMENT OUTCOME;

AGED; DIAGNOSTIC IMAGING; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; MYOCARDIUM; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; RISK ASSESSMENT; RISK FACTORS; TISSUE SURVIVAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84860798337     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.111.964668     Document Type: Article

References (58)

1. Libby P, Bonow R, Zipes D, Mann D. Baunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia, PA: Elsevier; 2007.
2. Stirrup J, Maenout A, Wechalekar K, Anagnostopoulos C. Radionuclide imaging in ischemic heart failure. Br Med Bull. 2009;92:43-59.
3. Vanoverschelde J, Wijins W, Depre C, Essamri B, Heyndrick G, Borgers M, Bol A, Melin JA. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation. 1993;87:1513-1523. (Pubitemid 23133095)
4. Camici PH, Prasad SK, Rimoldi OE. Stunning, hibernation and assessment of myocardial viability. Circulation. 2008;117:103-114. (Pubitemid 350301145)
5. Ghosh N, Rinoldi O, Beanlands R, Camici PG. Assessment of myocardial ischemia and viability. Role of PET. Eur Heart J. 2010;31:2984-2995.
6. Gheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkely PF, Prior DL, Rouleau JL. Navigating the crossroads of coronary artery disease and heart failure. Circulation. 2006;114:1202-1213. (Pubitemid 44386485)
7. Passamani E, Davis KB, Gillespie M, Killip T. A randomized trial of coronary artery bypass surgery: survival of patients with a low ejection fraction. N Engl J Med. 1985;312:1665-1671. (Pubitemid 15068573)
8. Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, Levie F, Schloss M. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 1983;68:785-795. (Pubitemid 13019226)
9. Yusus S, Zucker D, Peduzzi P, Fisher LD, Takero T, Kennedy JW, Davis K, killip T, Norris R. Effect of coronary artery bypass graft survival on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344:563-570. (Pubitemid 24267213)
10. Beanlands RS, Chow BJ, Dick A, Friedrich MG, Gulenchyn KY, Kiess M, Leong-Poi H, Miller RM, Nichol G, Freeman M, Bogaty P, Honos G, Hudon G, Wisenberg G, Van Berkom J, Williams K, Yoshinaga K, Graham J; Canadian Cardiovascular Society; Canadian Association of Radiologists; Canadian Association of Nuclear Medicine; Canadian Nuclear Cardiology Society; Canadian Society of Cardiac Magnetic Resonance. CCS/CAR/CANM/CNCS/CANSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease-executive summary. Can J Cardiol. 2007;23:107-119. (Pubitemid 46655426)
11. Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA; American College of Cardiology Foundation Appropriateness Criteria Task Force; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association for Thoracic Surgery; American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography; Heart Failure Society of America; Society of Cardiovascular Computed Tomography. ACCF/SCAI/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2009;53:530-553.
12. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW; American College of Cardiology Foundation; American Heart Association. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;54:e1-e90.
13. Arnold JM, Liu P, Demers C, Dorian P, Giannetti N, Haddad H, Heckman GA, Howlett JG, Ignaszewski A, Johnstone DE, Jong P, McKelvie RS, Moe GW, Parker JD, Rao V, Ross HJ, Sequeira EJ, Svendsen AM, Teo K, Tsuyuki RT, White M; Canadian Cardiovascular Society. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol. 2006;22:23-45.
14. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388-2442.
15. Arnold MJ, Howlett JG, Ducharme A Ezekowitz JA, Gardner MJ, Giannetti N, Haddad H, Heckman GA, Isaac D, Jong P, Liu P, Mann E, McKelvie RS, Moe GW, Svendsen AM, Tsuyuki RT, O'Halloran K, Ross HJ, Sequeira EJ, White M; Canadian Cardiovascular Society. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure-2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol. 2008;24:21-40. (Pubitemid 351385400)
16. Yoshinaga K, Chow BJ, Williams K, Chen L, deKemp RA, Garrard L, Lok-Tin SA, Aung M, Davies RA, Ruddy T, Beanlands RS. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol. 2006;48:1029-1039. (Pubitemid 44292462)
17. Dorbala S, Hachamovitch R, Kwong RY, Di Carli MF. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. J Am Coll Cardiol Cardiovasc Imaging. 2009;2:846-854.
18. Lertsburapa K, Ahlberg AW, Heller GV Bateman TM, Katten D, Volker L, Cullom SJ, Heller GV. Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium-82 PET imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol. 2008;15:745-753.
19. Buckley O, Di Carli M. Predicting benefit from revascularization in patients with ischemic heart failure. Circulation. 2011;123:444-450.
20. Hachamovitch R, Hayes SW, Friedman JD Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared to medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion singly photon emission computed tomography. Circulation. 2003;107:2900-2907.
21. Hachamovitch R, Berman DS, Shaw LJ, Kiat Hm Cohen I, Cabico JA, Friedman J, Diamond GA. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998;97:535-543. (Pubitemid 28090682)
22. Velazquez EJ, Lee KL, Deja M, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL; STICH Investigators. Coronaryartery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364:1607-1616.
23. Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. Management of heart failure, III: the role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA. 1994;272:1528-1534. (Pubitemid 24340796)
24. Di Carli MF, Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. Circulation. 2007;115:1464-1480. (Pubitemid 46648384)
25. Cleland JG, Pennel D, Ray S, Murray G, MacFarlane P, Cowley A, Coats A, Lahiri A; CHRISTMAS Study Steering Committee and Investigators. The Carvedilol Hibernation Reversible Ischemia Trial; Marker of Success (CHRISTMAS). Eur J Heart Fail. 1999;1:191-196. (Pubitemid 30186711)
26. Inaba Y, Chen JA, Bermann SR. Quantity of viable myocardium required to improve survival with revascularization in patients with ischemic cardiomyopathy: a meta-analysis. J Nucl Cardiol. 2010;17:646-654.
27. Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME, Maddahi J. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation. 1995;92:3436-3444.
28. Shukla T, Nichol G, Wells G, Dekemp RA, Davies RA, Haddad H, Duchesne L, Freeman M, Gulenchyn K, Racine N, Humen D, Benard F, Ruddy TD, Chow BJ, Dasilva J, Garrard L, Guo A, Chen L, Beanlands RS. Does FDG PET-assisted management of patients with left ventricular dysfunction improve quality of life? A substudy of the PARR-2 trial. Can J Cardiol. 2012;28:54-61.
29. Jacklin PB, Barrington SF, Roxburgh JC, Jackson G, Sariklis D, West PA, Maisey MN. Cost-effectiveness of preoperative positron emission tomography in ischemic heart disease. Ann Thorac Surg. 2002;73:1403-1410.
30. Schinkel AFL, Bax JJ, Poldermands D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol. 2007;32:375-410. (Pubitemid 46881171)
31. Nakata T, Hashimoto A, Wakabayashi T, Kusoka H, Nishimura T. Prediction of new-onset refractory congestive heart failure using gated myocardial perfusion SPECT imaging in patients with known or suspected coronary artery disease subanalysis of the J-ACCESS database. JACC Cardiovasc Imaging. 2009;2:1393-1400.
32. Hachamovitch R, Rozanski A, Hayes SW, Berman DS. Predicting therapeutic benefit from myocardial revascularization procedures: are measurements of both resting left ventricular ejection fraction and stress induced myocardial ischemia necessary? J Nucl Cardiol. 2006;13:768-778. (Pubitemid 44913652)
33. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151-1158. (Pubitemid 34267418)
34. D'Egidio G, Nichol G, Williams K, Guo A, Garrard L, deKemp R, Ruddy TD, DaSilva J, Humen D, Gulenchyn KY, Freeman M, Racine N, Benard F, Hendry P, Beanlands RS; PARR-2 Investigators. Identification of high risk patients with increasing ischemic cardiomyopathy. JACC Cardiovasc Imaging. 2009;2:1060-1068.
35. Hanekom L, Jenkins C, Jeffries L, Case C, Mundy J, Hawley C, Marwick TH. Incremental value of strain rate analysis as an adjunct to wall-motion scoring for assessment of myocardial viability by dobutamine echocardiography: a follow-up study after revascularization. Circulation. 2005; 112:3892-3900. (Pubitemid 43739487)
36. Ling LH, Christian TF, Mulvagh SL, Klarich KW, Hauser MF, Nishimura RA, Pellikka PA. Determining myocardial viability in chronic ischemic left ventricular dysfunction: a prospective comparison of rest-redistribution thallium-201 single-photon emission computed tomography, nitroglycerindobutamine echocardiography, and intracoronary myocardial contrast echocardiography. Am Heart J. 2006;151:882-889.
37. Kim RJ, Hillenbrands HB, Judd RM. Evaluation of myocardial viability by MRI. Herz. 2000;25:417-430. (Pubitemid 30470081)
38. Bettencourt N, Chiribiri A, Schuster A, Nagel E. Assessment of myocardial ischemia and viability using cardiac magnetic resonance. Curr Heart Fail Reports. 2009;6:142-153.
39. Pegg TJ, Selvanayagam JB, Jennifer J, Francis JM, Karamitsos TD, Dall'Armellina E, Smith KL, Taggart DP, Neubauer S. Prediction of global left ventricular functional recovery in patients with heart failure undergoing surgical revascularisation, based on late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2010;12:56.
40. Kwon DH, Halley CM, Carrigan TP, Zysek V, Popovic ZB, Setser R, Schoenhagen P, Starling RC, Flamm SD, Desai MY. Extent of left ventricular scar predicts outcomes in patients with ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. J Am Coll Cardiol Cardiovasc Imaging. 2009;2:34-44.
41. Lauerma K, Niemi P, Hanninen H, Janatuinen T, Voipio-Pulkki LM, Knuuti J, Toivonen L, Mäkelä T, Mäkijärvi MA, Aronen HJ. Multimodality MR imaging assessment of myocardial viability: combination of first pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET initial experience. Radiology. 2000;217:729-736.
42. Selvanayagam JB, Kardos A, Francis JM, Wiesmann F, Petersen SE, Taggart DP, Neubauer S. Value of delayed enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation. 2004;110:1535-1541. (Pubitemid 39297973)
43. Wellnhofer E, Olariu A, Klein C, Gräfe M, Wahl A, Fleck E, Nagel E. Magnetic resonance low dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation. 2004;109:2172-2174. (Pubitemid 38625392)
44. Gutberlet F, Frohlich M, Mehl S Amthauer H, Hausmann H, Meyer R, Siniawski H, Ruf J, Plotkin M, Denecke T, Schnackenburg B, Hetzer R, Felix R. Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and T1201-SPECT with functional recovery after revascularization. Euro Radiol. 2005;15:872-880. (Pubitemid 41166718)
45. Beek AM, Bondarenko O, Afsharzada F, van Rossum AC. Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome. J Cardiovasc Magnetic Reson. 2009;11:6.
46. Kim RJ, Wu E, Rafael C, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
47. Eitzman D, Al-Aouar Z, Kanter HL, vom Dahl J, Kirsch M, Deeb GM, Schwaiger M. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol. 1992;20:559-565.
48. Yoshida K, Gould KL. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3 year mortality with and without revascularization. J Am Coll Cardiol. 1993;22:984-997. (Pubitemid 23285746)
49. Abraham A, Nichol G, Williams KA, Guo A, deKemp RA, Garrard L, Davies RA, Duchesne L, Haddad H, Chow B, DaSilva J, Beanlands RS; PARR 2 Investigators. 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial. J Nucl Med. 2010;51:567-574.
50. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201Ti imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary artery bypass surgery in patients with severely depressed left ventricular function. Circulation. 1993;87:1630-1641. (Pubitemid 23133108)
51. Rizzello V, Poldermans D, Biagini E, Schnikel AF, Boersma E, Boccanelli A, Marwick T, Roelandt JR, Bax JJ. Prognosis of patients with ischemic cardiomyopathy after coronary revascularization: relation to viability and improvement in left ventricular ejection fraction. Heart. 2009;95:1273-1277.
52. Samady H, Elefteriades JA, Abbott BG, Mattera JA, McPherson CA, Wackers FJ. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation. 1999;100:1298-1304. (Pubitemid 29440122)
53. Haas F, Haehnel CJ, Picker W, Nekolla S, Martinoff S, Meisner H, Schwaiger M. Preoperative positron emission tomographic viability assessment and perioperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol. 1997;30:1693-1700. (Pubitemid 27521251)
54. Mule JD, Bax JJ, Zingone B, Burelli C, Stefania A, DiSipio L, Sarvia G. The beneficial effect of revascularization on jeopardized myocardium: reverse remodeling and improved long-term prognosis. Eur J Cardiothorac Surg. 2002;22:426-430. (Pubitemid 36153073)
55. Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, Gulenchyn KY, De Kemp R, Guo A, Ruddy T, Benard F, Lamy A, Iwanochoko RM; PARR2 Investigators. F18 positron emission tomography imaging assisted management of patients with severe left ventricular dysfunction and suspected coronary disease. J Am Col Cardiol. 2007;50:2002-2012. (Pubitemid 350054917)
56. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, Czernin J, Rokhsar S, Stevenson LW, Laks H. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 1994;73:527-533. (Pubitemid 24142581)
57. Shaw LJ, Berman DS, Maron DJ Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O'Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE; COURAGE Investigators. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;177:1283-1291. (Pubitemid 351365675)
58. Bonow RO, Maurer G, Lee KL, Holly TA, Holly TA, Binkley PF, Desvigne-Nickens P, Drozdz J, Farsky PS, Feldman AM, Doenst T, Michler RE, Berman DS, Nicolau JC, Pellikka PA, Wrobel K, Alotti N, Asch FM, Favaloro LE, She L, Velazquez EJ, Jones RH, Panza JA; STICH Trial Investigators. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617-1625.